Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Schedule an appointment today
Call to Schedule: 1-866-UH4-CARE
Radiation Oncology

Image Guided Radiation Therapy (IGRT)

Department of Radiation Oncology Offers Image Guided Radiation Therapy to Limit Dose to Healthy Tissues

The Department of Radiation Oncology at University Hospitals Seidman Cancer Center in Cleveland, Ohio, offers advanced image guided radiation therapy (IGRT) for tumor regression, eradication and cure.

Precision Imaging Technology and Molecular Imaging Specialties

Using exact images generated from Magnetic Resonance Imaging (MRI), Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), or Computed Tomography (CT), our oncologists can fuse or precisely align the highest degree of cancer therapy available.

Radiation oncologists at UH can define cancerous tumor volumes in relationship to the state of the tumor and surrounding healthy tissue. Then using this thorough information, experts can accurately target active areas of tumor growth with image guided radiation that may lead to a higher cancer cure and management rate.

The Department of Radiation Oncology offers leading-edge, advanced molecular imaging specialties, including:

  • Image fusion for radiation therapy planning Positron emission tomography (PET) scan
  • PET-magnetic resonance imaging (MRI)
  • Single-photon emission computed tomography (SPECT)

With these powerful imaging tools our experts can reduce side effects by giving higher doses of radiation while minimizing risks to surrounding healthy tissue.

Advanced Technology with Convenient Access

Easy access to our comprehensive cancer services are conveniently located all under one roof at UH Seidman Cancer Center. Our multidisciplinary team of experts works together for improved patient outcomes through medical oncology, radiation oncology, support programs, and clinical trials.